ARTS COPPENS MIEKE, anatome pathologie
0860.945.076 · rovalta.com · 27/09/2026
ARTS COPPENS MIEKE, anatome pathologie
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOARTS COPPENS MIEKE, anatome pathologie is a Private company with limited liability incorporated in 2003. Its registered office is in Gavere.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0860.945.076
- Incorporation
- 08/10/2003
- Legal form
- Private company with limited liability
- Registered office
- Heilige Donatusstraat 2
9890 Gavere · FlandreSee on map - Contributed capital
- 27 500,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,3 M € | +14.4% | 1,2 M € | +5.8% | 1,1 M € | +2.4% | 1,1 M € | -4.4% | 1,1 M € |
| EBITDA | 1,3 M € | +14.5% | 1,2 M € | +5.9% | 1,1 M € | +2.4% | 1,1 M € | -4.4% | 1,1 M € |
| Operating result | 1,3 M € | +14.4% | 1,2 M € | +5.9% | 1,1 M € | +3.2% | 1,1 M € | -3.2% | 1,1 M € |
| Net result | 910 k € | +13.5% | 801,8 k € | +7.0% | 749 k € | +3.4% | 724,7 k € | -3.2% | 748,4 k € |
| Balance sheet | |||||||||
| Equity | 4,7 M € | +8.3% | 4,3 M € | +8.2% | 4 M € | +23.1% | 3,2 M € | +28.8% | 2,5 M € |
| Total assets | 4,7 M € | +9.0% | 4,3 M € | +7.1% | 4 M € | +23.2% | 3,3 M € | +28.9% | 2,5 M € |
| Cash | 555,9 k € | +1497% | 34,8 k € | -99.1% | 3,9 M € | +28.7% | 3,1 M € | +25.8% | 2,4 M € |
| Debts | 31,5 k € | – | 39,6 k € | +29.3% | 30,7 k € | +44.6% | 21,2 k € | ||
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/01/2026 | 31/12/2024 | 30/01/2024 | 23/12/2022 | 28/12/2021 | 08/01/2021 |
| General meeting | 15/12/2025 | 16/12/2024 | 31/12/2023 | 30/11/2022 | 30/11/2021 | 15/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 15/12/2025 | 14/01/2026 | Dutch | |
| Abridged model | 30/06/2024 | 16/12/2024 | 31/12/2024 | Dutch | |
| Abridged model | 30/06/2023 | 31/12/2023 | 30/01/2024 | Dutch | |
| Abridged model | 30/06/2022 | 30/11/2022 | 23/12/2022 | Dutch | |
| Abridged model | 30/06/2021 | 30/11/2021 | 28/12/2021 | Dutch | |
| Abridged model | 30/06/2020 | 15/12/2020 | 08/01/2021 | Dutch | |
| Abridged model | 30/06/2019 | 30/11/2019 | 31/12/2019 | Dutch | |
| Abridged model | 30/06/2018 | 30/11/2018 | 21/12/2018 | Dutch | |
| Abridged model | 30/06/2017 | 30/11/2017 | 29/12/2017 | Dutch | |
| Abridged model | 30/06/2016 | 30/11/2016 | 28/12/2016 | Dutch | |
| Abridged model | 30/06/2015 | 30/11/2015 | 29/12/2015 | Dutch | |
| Abridged model | 30/06/2014 | 30/11/2014 | 30/12/2014 | Dutch | |
| Abridged model | 30/06/2013 | 30/11/2013 | 23/12/2013 | Dutch | |
| Abridged model | 30/06/2012 | 30/11/2012 | 28/12/2012 | Dutch | |
| Abridged model | 30/06/2011 | 30/11/2011 | 29/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 30/11/2010 | 28/12/2010 | Dutch | |
| Abridged model | 30/06/2009 | 30/11/2009 | 11/12/2009 | Dutch | |
| Abridged model | 30/06/2008 | 30/11/2008 | 04/12/2008 | Dutch | |
| Abridged model | 30/06/2007 | 15/12/2007 | 04/01/2008 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025910 k €↑
- 2024Annual accounts 2024801,8 k €↑
- 2024Name changeCOPPENS MIEKE
- 2023Annual accounts 2023749 k €↑
- 2023Name changeCOPPENS MIEKE ARTS
- 2022Annual accounts 2022724,7 k €↓
- 2022Name changeARTS COPPENS MIEKE, anatome pathologie
- 2021Annual accounts 2021748,4 k €↑
- 2020Annual accounts 2020673,4 k €↑
- 2019Annual accounts 2019553,1 k €↑
- 2018Annual accounts 2018477,5 k €↑
- 2017Annual accounts 2017469,8 k €↓
- 2016Annual accounts 2016510,1 k €↑
- 2015Annual accounts 2015475,4 k €↑
- 2014Annual accounts 2014294,1 k €↓
- 2013Annual accounts 2013316,9 k €↓
- 2012Annual accounts 2012350,6 k €↑
- 2011Annual accounts 2011329 k €↑
- 2010Annual accounts 2010296,1 k €↓
- 2009Annual accounts 2009457,9 k €↑
- 2008Annual accounts 2008210 k €↓
- 2007Annual accounts 2007342,4 k €
- 08/10/2003IncorporationPrivate company with limited liability